Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises
Moaçir Wajner, Carmen Regla Vargas
Abstract
Open-access reader
Moaçir Wajner, Carmen Regla Vargas
Abstract
Open-access reader
Editor,—Neurological dysfunction is a major clinical feature of children with maple syrup urine disease (MSUD). However, the mechanisms underlying the neuropathophysiology of the disorder are poorly known. There is some evidence associating the appearance of the neurological symptoms with increased plasma concentrations of leucine or its ketoacid, α ketoisocaproic acid or both.1 Impairment of brain energy production by inhibition of key mitochondrial enzymes by the acidic metabolites that accumulate in this disease has also been reported.2 …
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Editor,—Neurological dysfunction is a major clinical feature of children with maple syrup urine disease (MSUD). However, the mechanisms underlying the neuropathophysiology of the disorder are poorly known. There is some evidence associating the appearance of the neurological symptoms with increased plasma concentrations of leucine or its ketoacid, α ketoisocaproic acid or both.1 Impairment of brain energy production by inhibition of key mitochondrial enzymes by the acidic metabolites that accumulate in this disease has also been reported.2 …
Key concepts: Maple syrup urine disease, Medicine, Leucine, Urine, Amino acid, Disease, Internal medicine, Biochemistry